NTRZ had help wanted in the Lake Charles, Louisiana paper meaning that the new plant will be on time.
And the lone analyst put 09 revenue and earnings estimates up. A little conservative in my opinion.
Third, an Aids study with a university in Israel is due to have preliminary results out soon as to SRB and improving the immune system of Aids victims. If it is great, Ellen DeGeneres types could really hype the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.